/biz/ - Business & Finance

Also I feel bad for this guy, the fact he's spent his career helping many others but can't save himself is relatable somehow.

How low is it going frens

Title, I want to hear what biz thinks.

Post ur answers, no matter how insane it sounds.

>>15209241
>le blackpill psyop
not today CIA

>>14947033
This.

>being a literal male feminist that thinks that a good looking girl, of the sort which are in frighteningly low supply these days, is "the worst" for not giving herself up for you at your most broke, unmotivated and slovenly as opposed to the you today that's greatly improved himself physically, mentally and financially

The real problem here is entitlement. That said, you both probably don't have anything in common anyway

Seeing as 99% of people lose their ass in crypto is starting a business the only real reliable way to 100x?

In restaurants in the U.S. serving staff are treated like independent contractors; the cooks and other staff make a higher wage but the serving staff in particular make less because gratuity is a customary thing. Their final wages are often performance based-and sometimes suprisingly high-as consequence.

In the US less than 4% of workers earn the federal minimum wage or below, but close to 100% of those workers are in gratuity-earning positions and are likely taking home more than many of those earning the "living wage" meme do.

The custom of gratuity improves service, lowers overhead and prices, and gives workers who'd otherwise be on the bottom rung of the economic ladder several hundred dollars in untaxed (depending on establishment) income a week.

https://www.numbeo.com/cost-of-living/compare_cities.jsp?country1=United+States&country2=United+Kingdom&city1=San+Antonio%2C+TX&city2=London&tracking=getDispatchComparison

>>14528866
I bring r&d up often just to highlight the initial costs of producing a drug, and I bring the Novo Nordisk and Sanofi examples up because they're two European companies that charge the US market unsustainably high prices for their product (in this case insulin for which they enjoy a 76% combined market share) and charge European countries and others unsustainably low prices they wouldn't even break even on were these prices universal (as do they all). In this way, US firms may be responsible for "only" 60% of novel pharmacological products directly, but indirectly US consumers could be responsible for close to 90%-shit maybe more-as they're the ones paying for them regardless of their origin. It's market protectionism at its most insidious-even deadly-and it's been owed a measured response for decades.

>>14452770
I'll save you mommy!